长江生命科技旗下Sequencio Therapeutics在美国癌症研究协会年会展示疫苗研究最新突破

38
3
Favorite

长江生命科技旗下Sequencio Therapeutics在美国癌症研究协会年会展示疫苗研究最新突破

美股速递03-31 18:16

长江生命科技（股份代号：00775）旗下生物制药公司Sequencio Therapeutics，近日在美国癌症研究协会（AACR）年度会议上，公布了其在疫苗研发领域取得的最新进展。

此次展示聚焦于创新疫苗技术的临床前数据与作用机制，凸显了公司在肿瘤免疫治疗方向的深入布局。相关研究成果为后续临床应用及合作开发奠定了重要基础。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（3）

erichosk
·2021-09-02
Great
Reply
1
Report
Fold Replies
- KLS:
  Buybuy
  2021-09-02
  Reply
  Report
- YPT:
  [强] [强]
  2021-09-02
  Reply
  Report
leexy
·2021-09-02
Like and comment
Reply
4
Report
Fold Replies
- ckww:
  Ok
  2021-09-02
  Reply
  Report
- Stellin:
  Grear
  2021-09-02
  Reply
  Report
Adollar
·2021-09-02
Good job !
Reply
6
Report
Fold Replies
- oohsodope:
  yes
  2021-09-02
  Reply
  Report
- doubleDees:
  ok
  2021-09-02
  Reply
  Report
- leexy:
  Cool bro
  2021-09-02
  Reply
  Report

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1189053459?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-03-31 18:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189053459","market":"us","top_or_hot":-1,"title":"长江生命科技旗下Sequencio Therapeutics在美国癌症研究协会年会展示疫苗研究最新突破","media":"美股速递","content":"<p>长江生命科技（股份代号：00775）旗下生物制药公司Sequencio Therapeutics，近日在美国癌症研究协会（AACR）年度会议上，公布了其在疫苗研发领域取得的最新进展。</p>\n<p>此次展示聚焦于创新疫苗技术的临床前数据与作用机制，凸显了公司在肿瘤免疫治疗方向的深入布局。相关研究成果为后续临床应用及合作开发奠定了重要基础。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>长江生命科技旗下Sequencio Therapeutics在美国癌症研究协会年会展示疫苗研究最新突破</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n长江生命科技旗下Sequencio Therapeutics在美国癌症研究协会年会展示疫苗研究最新突破\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1004306016\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">美股速递 </p>\n<p class=\"h-time\">2026-03-31 18:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>长江生命科技（股份代号：00775）旗下生物制药公司Sequencio Therapeutics，近日在美国癌症研究协会（AACR）年度会议上，公布了其在疫苗研发领域取得的最新进展。</p>\n<p>此次展示聚焦于创新疫苗技术的临床前数据与作用机制，凸显了公司在肿瘤免疫治疗方向的深入布局。相关研究成果为后续临床应用及合作开发奠定了重要基础。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1569","symbol_name":"长和系","start_time":0,"source_url":"","article_id":"1189053459","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189053459","pubTimestamp":1774952199,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"长江生命科技（股份代号：00775）旗下生物制药公司Sequencio Therapeutics，近日在美国癌症研究协会（AACR）年度会议上，公布了其在疫苗研发领域取得的最新进展。\n此次展示聚焦于创新疫苗技术的临床前数据与作用机制，凸显了公司在肿瘤免疫治疗方向的深入布局。相关研究成果为后续临床应用及合作开发奠定了重要基础。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1569":"长和系","BK1161":"生物科技","00775":"长江生命科技"},"translate_title":"全球审查后，苹果允许媒体应用免30%手续费","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00775":1},"content_text":"长江生命科技（股份代号：00775）旗下生物制药公司Sequencio Therapeutics，近日在美国癌症研究协会（AACR）年度会议上，公布了其在疫苗研发领域取得的最新进展。\n此次展示聚焦于创新疫苗技术的临床前数据与作用机制，凸显了公司在肿瘤免疫治疗方向的深入布局。相关研究成果为后续临床应用及合作开发奠定了重要基础。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":812813533,"gmtCreate":1630572368622,"gmtModify":1676530343949,"author":{"id":"3575433293784452","authorId":"3575433293784452","name":"erichosk","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":1,"crmLevelSwitch":0,"idStr":"3575433293784452","authorIdStr":"3575433293784452"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/812813533","repostId":1189053459,"repostType":4,"repost":{"id":"1189053459","kind":"news","weMediaInfo":{"introduction":"全球快讯第一时间播报","home_visible":1,"media_name":"美股速递","id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"pubTimestamp":1774952199,"share":"https://ttm.financial/m/news/1189053459?lang=en_US&edition=fundamental","pubTime":"2026-03-31 18:16","market":"us","language":"zh","title":"Sequencio Therapeutics, a subsidiary of CK Life Sciences, presents latest breakthroughs in vaccine research at the annual meeting of the American Association for Cancer Research","url":"https://stock-news.laohu8.com/highlight/detail?id=1189053459","media":"美股速递","summary":"长江生命科技（股份代号：00775）旗下生物制药公司Sequencio Therapeutics，近日在美国癌症研究协会（AACR）年度会议上，公布了其在疫苗研发领域取得的最新进展。\n此次展示聚焦于创新疫苗技术的临床前数据与作用机制，凸显了公司在肿瘤免疫治疗方向的深入布局。相关研究成果为后续临床应用及合作开发奠定了重要基础。","content":"<p>Sequencio Therapeutics, a biopharmaceutical company under CK Life Sciences (stock code: 00775), recently announced its latest progress in the field of vaccine research and development at the annual meeting of the American Association for Cancer Research (AACR).</p><p>This display focuses on preclinical data and mechanism of action of innovative vaccine technology, highlighting the company's in-depth layout in the direction of tumor immunotherapy. The relevant research results have laid an important foundation for subsequent clinical application and cooperative development.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sequencio Therapeutics, a subsidiary of CK Life Sciences, presents latest breakthroughs in vaccine research at the annual meeting of the American Association for Cancer Research</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSequencio Therapeutics, a subsidiary of CK Life Sciences, presents latest breakthroughs in vaccine research at the annual meeting of the American Association for Cancer Research\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1004306016\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">美股速递 </p>\n<p class=\"h-time smaller\">2026-03-31 18:16</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Sequencio Therapeutics, a biopharmaceutical company under CK Life Sciences (stock code: 00775), recently announced its latest progress in the field of vaccine research and development at the annual meeting of the American Association for Cancer Research (AACR).</p><p>This display focuses on preclinical data and mechanism of action of innovative vaccine technology, highlighting the company's in-depth layout in the direction of tumor immunotherapy. The relevant research results have laid an important foundation for subsequent clinical application and cooperative development.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK1569":"长和系","BK1161":"生物科技","00775":"长江生命科技"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189053459","content_text":"长江生命科技（股份代号：00775）旗下生物制药公司Sequencio Therapeutics，近日在美国癌症研究协会（AACR）年度会议上，公布了其在疫苗研发领域取得的最新进展。\n此次展示聚焦于创新疫苗技术的临床前数据与作用机制，凸显了公司在肿瘤免疫治疗方向的深入布局。相关研究成果为后续临床应用及合作开发奠定了重要基础。","news_type":1,"symbols_score_info":{"00775":1}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5729542,"gmtCreate":1630578613292,"gmtModify":1663233281527,"authorId":3551655093075927,"author":{"id":3551655093075927,"idStr":"3551655093075927","authorId":3551655093075927,"name":"KLS","avatar":"https://static.tigerbbs.com/60fe00969bbce4cfecf0d17a38c77628","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":812813533,"type":1,"supId":5728895,"prevId":0,"content":"<u>Buybuy</u>","text":"<u>Buybuy</u>","html":"<u>Buybuy</u>"},{"id":5728895,"gmtCreate":1630573122196,"gmtModify":1663233278329,"authorId":3579838075158745,"author":{"id":3579838075158745,"idStr":"3579838075158745","authorId":3579838075158745,"name":"YPT","avatar":"https://static.tigerbbs.com/10baea998b9915ab14ba326ad1c4a2a6","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":812813533,"type":1,"supId":0,"prevId":0,"content":"[强] [强]","text":"[强] [强]","html":"[强] [强]"}],"langContent":"EN"},{"id":812830833,"gmtCreate":1630571369822,"gmtModify":1676530343596,"author":{"id":"3563930588845537","authorId":"3563930588845537","name":"leexy","avatar":"https://community-static.tradeup.com/news/7ea3c1dd8f5530e34ee12b947618beac","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3563930588845537","authorIdStr":"3563930588845537"},"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/812830833","repostId":1189053459,"repostType":4,"repost":{"id":"1189053459","kind":"news","weMediaInfo":{"introduction":"全球快讯第一时间播报","home_visible":1,"media_name":"美股速递","id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"pubTimestamp":1774952199,"share":"https://ttm.financial/m/news/1189053459?lang=en_US&edition=fundamental","pubTime":"2026-03-31 18:16","market":"us","language":"zh","title":"Sequencio Therapeutics, a subsidiary of CK Life Sciences, presents latest breakthroughs in vaccine research at the annual meeting of the American Association for Cancer Research","url":"https://stock-news.laohu8.com/highlight/detail?id=1189053459","media":"美股速递","summary":"长江生命科技（股份代号：00775）旗下生物制药公司Sequencio Therapeutics，近日在美国癌症研究协会（AACR）年度会议上，公布了其在疫苗研发领域取得的最新进展。\n此次展示聚焦于创新疫苗技术的临床前数据与作用机制，凸显了公司在肿瘤免疫治疗方向的深入布局。相关研究成果为后续临床应用及合作开发奠定了重要基础。","content":"<p>Sequencio Therapeutics, a biopharmaceutical company under CK Life Sciences (stock code: 00775), recently announced its latest progress in the field of vaccine research and development at the annual meeting of the American Association for Cancer Research (AACR).</p><p>This display focuses on preclinical data and mechanism of action of innovative vaccine technology, highlighting the company's in-depth layout in the direction of tumor immunotherapy. The relevant research results have laid an important foundation for subsequent clinical application and cooperative development.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sequencio Therapeutics, a subsidiary of CK Life Sciences, presents latest breakthroughs in vaccine research at the annual meeting of the American Association for Cancer Research</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSequencio Therapeutics, a subsidiary of CK Life Sciences, presents latest breakthroughs in vaccine research at the annual meeting of the American Association for Cancer Research\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1004306016\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">美股速递 </p>\n<p class=\"h-time smaller\">2026-03-31 18:16</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Sequencio Therapeutics, a biopharmaceutical company under CK Life Sciences (stock code: 00775), recently announced its latest progress in the field of vaccine research and development at the annual meeting of the American Association for Cancer Research (AACR).</p><p>This display focuses on preclinical data and mechanism of action of innovative vaccine technology, highlighting the company's in-depth layout in the direction of tumor immunotherapy. The relevant research results have laid an important foundation for subsequent clinical application and cooperative development.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK1569":"长和系","BK1161":"生物科技","00775":"长江生命科技"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189053459","content_text":"长江生命科技（股份代号：00775）旗下生物制药公司Sequencio Therapeutics，近日在美国癌症研究协会（AACR）年度会议上，公布了其在疫苗研发领域取得的最新进展。\n此次展示聚焦于创新疫苗技术的临床前数据与作用机制，凸显了公司在肿瘤免疫治疗方向的深入布局。相关研究成果为后续临床应用及合作开发奠定了重要基础。","news_type":1,"symbols_score_info":{"00775":1}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5728879,"gmtCreate":1630572976894,"gmtModify":1663233278136,"authorId":3581586523786578,"author":{"id":3581586523786578,"idStr":"3581586523786578","authorId":3581586523786578,"name":"ckww","avatar":"https://static.tigerbbs.com/bc2cc1ef6533d547201ce880e7c04b9c","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":812830833,"type":1,"supId":0,"prevId":0,"content":"<u>Ok</u>","text":"<u>Ok</u>","html":"<u>Ok</u>"},{"id":5728663,"gmtCreate":1630571381726,"gmtModify":1663233275239,"authorId":3573195706826515,"author":{"id":3573195706826515,"idStr":"3573195706826515","authorId":3573195706826515,"name":"Stellin","avatar":"https://static.tigerbbs.com/64d9f3f1aef29a95e764613cdcccff23","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":812830833,"type":1,"supId":0,"prevId":0,"content":"Grear","text":"Grear","html":"Grear"}],"langContent":"EN"},{"id":812898821,"gmtCreate":1630570906663,"gmtModify":1676530343467,"author":{"id":"3582843618871796","authorId":"3582843618871796","name":"Adollar","avatar":"https://static.tigerbbs.com/0b7c3e8d0ea455e203fda09d0d2cffb8","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3582843618871796","authorIdStr":"3582843618871796"},"htmlText":"Good job !&nbsp;","listText":"Good job !&nbsp;","text":"Good job !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/812898821","repostId":1189053459,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5728618,"gmtCreate":1630571032163,"gmtModify":1663233279026,"authorId":4088296712073280,"author":{"id":4088296712073280,"idStr":"4088296712073280","authorId":4088296712073280,"name":"oohsodope","avatar":"https://community-static.tradeup.com/news/6962460538ca42adce5ec6388d8a8a67","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":812898821,"type":1,"supId":0,"prevId":0,"content":"yes","text":"yes","html":"yes"},{"id":5728619,"gmtCreate":1630571035321,"gmtModify":1635132932838,"authorId":3573265010793105,"author":{"id":3573265010793105,"idStr":"3573265010793105","authorId":3573265010793105,"name":"doubleDees","avatar":"https://static.tigerbbs.com/2c61dade65d42065972c6833062a92ed","vip":1,"crmLevel":12,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":812898821,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":5728664,"gmtCreate":1630571382227,"gmtModify":1635132929552,"authorId":3563930588845537,"author":{"id":3563930588845537,"idStr":"3563930588845537","authorId":3563930588845537,"name":"leexy","avatar":"https://community-static.tradeup.com/news/7ea3c1dd8f5530e34ee12b947618beac","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":812898821,"type":1,"supId":0,"prevId":0,"content":"Cool bro","text":"Cool bro","html":"Cool bro"}],"langContent":"EN"}],"hasMoreComments":false,"newsSizeData":{"likeSize":38,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}